Skip to main content

New York Times article breaks down barriers to recruitment and brings hope with a new trial

By July 27, 2018Commentary, In the News

Photo credit: Zack Wittman for The New York Times

The New York Times recently covered a new clinical trial effort Eli Lilly is undertaking, the TRAILBLAZER-ALZ clinical research study. The study, which UCI MIND investigators are participating in, aims to enroll 375 people with early Alzheimer’s disease. To learn more about the TRAILBLAZER-ALZ study, click here, or contact us at or call 949.824.0008.